Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
EV/Core EBITDA

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 9.0215.6812.236.325.18

What is the latest EV/Core EBITDA ratio of MARKSANS PHARMA ?

The latest EV/Core EBITDA ratio of MARKSANS PHARMA is 9.02 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar20269.02
Mar202515.68
Mar202412.23
Mar20236.32
Mar20225.18

How is EV/Core EBITDA of MARKSANS PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 9.02
-42.47
Mar2025 15.68
28.21
Mar2024 12.23
93.51
Mar2023 6.32
22.01
Mar2022 5.18 -

Other Financial Ratios of MARKSANS PHARMA


Compare EV/Core EBITDA ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹14,493.3 Cr -2.6% -2.3% 84.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2.6%

-2.3%

84.5%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses